DISCLAIMER
The information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.message sent
email sent successfully
You are receiving this because you have an account on www.oneGRAVESvoice.com | ||
To unsubscribe from these emails, click here |
Trusted Resources: News & Meetings
Latest announcements and gatherings
World Sight Day 2019 – Speaker Event with Susan Robinson
World Sight Day 2019 with speaker Susan Robinson – A leader who blends 25+ years of multi-sector leadership with her experiences being legally blind to shift thinking, elevate potential and inspire action.
World Sight Day is an annual day of awareness to focus global attention on blindness and visual impairment. The event is celebrated by holding a large full-service vision screening for populations in need and hosting a speaking event to raise awareness about the challenges of living with and preventing vision impairment.
When:
October 3, 2019
6:30 PM – 8:30 PM EDT
Where:
Buckhead Club
3344 Peachtree Road Northeast
#Suite 2600
Atlanta, Georgia, United States.
The event has ended.
![World Sight Day 2019 – Speaker Event With Susan Robinson World Sight Day 2019 – Speaker Event With Susan Robinson](https://www.onegravesvoice.com/wp-content/uploads/2019/09/World-Sight-Day-2019-Speaker-Event-with-Susan-Robinson.jpg )
![](https://www.onegravesvoice.com/application/themes/onevoice-child/images/bookmark.png)
Related Content
-
Evidence & EducationKnowledge of Thyroid Eye Disease in Graves’ Disease Patients With and Without OrbitopathyBackground: Thyroid eye disease (TED) d...
-
News & MeetingsHorizon Therapeutics Announces the FDA has Granted Priority Review of the Teprotumumab Biologics License Application...Horizon Therapeutics plc today announced...
-
Evidence & EducationMeta-Analysis of Methylprednisolone Pulse Therapy for Graves’ OphthalmopathyA meta-analysis was performed to evaluat...
-
Evidence & EducationEfficacy and Safety of Mycophenolate Mofetil in Patients With Active Moderate-to-Severe Graves’ OrbitopathyContext: Graves' orbitopathy (GO) is a ...
-
Evidence & EducationProspectively Recorded and MedDRA-Coded Safety Data of Intravenous Methylprednisolone Therapy in Graves’ Orbit...Context: Safety of intravenous (IV) ste...
-
Evidence & EducationAdvances in the Pharmacological Treatment of Graves’ OrbitopathyGraves' orbitopathy has a deteriorating ...
-
Videos & VisualsGraves’ Disease Ophthalmology in Children and Adolescentshttps://youtu.be/ZTOU7SsvvQE...
send a message
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.